| 5-U01-EB026996-05 |
Connectome 2.0: Developing the next generation human MRI scanner for bridging studies of the micro-, meso- and macro-connectome |
Susie Huang |
Massachusetts General Hospital |
| 5-R01-EB031765-03 |
Connectome style neuroimaging in non human primates via novel integrated RF platforms |
Jan Zimmermann |
University of Minnesota |
| 5-R01-EB032746-03 |
CRCNS: Computational Modeling of Microvascular Effects in Cortical Laminar fMRI |
Jonathan Polimeni |
Massachusetts General Hospital |
| 1-R01-EB034978-01 |
Development and Translation of D-glucose as a Diagnostic Agent for MRI of Cancer |
Peter Van Zijl |
Hugo W. Moser Res Inst Kennedy Krieger |
| 5-R00-EB026312-05 |
Development and Translation of D-glucose as an MRI Contrast Agent for Multiple Sclerosis |
Xiang Xu |
Icahn School of Medicine at Mount Sinai |
| 5-U01-EB026412-05 |
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods |
Daniel Vigneron |
University of California, San Francisco |
| 5-K01-EB030039-04 |
Development of Advanced MRI for the Thoracolumbar Spinal Cord for Clinical Application |
Kristin O'Grady |
Vanderbilt University Medical Center |
| 5-R01-EB029985-04 |
Development of Enabling Technologies for Clinical Ultrahigh Field Body MRI |
Gregory Metzger |
University of Minnesota |
| 5-R03-EB030831-02 |
Development of High-Performance Multi-Contrast Echo Planar Imaging |
Stephan Maier |
Brigham And Women'S Hospital |
| 1-R21-EB032514-01A1 |
Development of Layer Specific FMRI for Clinical Scanners |
Luis Hernandez-Garcia |
University of Michigan at Ann Arbor |
